Get started
Author

Licet González Fabián

Observed names: González Fabian, Licet, González Fabian, Licet, González Fabián, Licet, L González Fabian, L.G. Fabian, Licet Gonzalez Fabian, Licet González Fabian
OpenAlex ID: A5113845953
Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study
2025 · Zobair M. Younossi, Leyla de Avila, et al. · Hepatology · 30
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study
2025 · Zobair M. Younossi, Leyla de Avila, et al. · Hepatology · 25
PDF
Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study
2026 · Zobair M. Younossi, Leyla de Avila, et al. · Clinical Gastroenterology and Hepatology · 16
Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba
2017 · Marlen Ivón Castellanos Fernández, Deyanira la Rosa Hernández, et al. · Current Therapeutic Research · 8
[Blastocystis hominis in symptomatic celiac patients].
2012 · Oscar Manuel Villa Jiménez, Angel Escobedo Carbonell, et al. · PubMed · 8
Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice
2018 · J. Ampuero, Rocío Aller, et al. · Journal of Hepatology · 5
Tolerance to treatment with standard interferon and ribavirin in patients presenting with cirrhosis from hepatitis C
2010 · Zaily Dorta Guridi, Marlen Castellanos Fernández, et al. · Revista Cubana de Medicina · 5
Autoimmune Hepatitis in Cuban Patients: A Retrospective Analysis of Clinical and Histological Profiles, Treatments, and Outcomes
2020 · Marlen Ivón Castellanos Fernández, Maria Edelina Cepeda Mullo, et al. · Current Therapeutic Research · 4
PDF
Comportamiento clínico, epidemiológico, endoscópico e histológico del cáncer gástrico de tipo epitelial
2016 · Alfredo Hierro González, Eugenia Paulo de Uime Ferreira, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2
Aterosclerosis cerebral: evaluación de la calidad de los diagnósticos premortem
2008 · Licet González Fabián, Rosa Campos Peña, et al. · 2
Histopathological characteristics in livers of deceased patients with COVID-19
2025 · Licet González Fabián, González Teresita Teresita de Jesús González, et al. · Metabolism and Target Organ Damage · 1
PDF
Seudohipoparatiroidismo 1b
2020 · Ana Elena Arús Fernández, Licet González Fabian, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Caracterización de pacientes con colitis ulcerosa atendidos en centro de nivel terciario
2016 · Olga Marina Hano García, Solange Andrade Gomes, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Caracterización de pacientes con enfermedad de Crohn atendidos en el Instituto de Gastroenterología de Cuba
2014 · Olga Marina Hano García, Solange Andrade Gomes, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Manifestaciones hepatobiliares en pacientes con enfermedad inflamatoria crónica intestinal
2012 · Olga Marina Hano García, Yirian Tatiana Ojeda Abizaid, et al. · Revista cubana de investigaciones biomédicas · 1
Nutritional assessment of compensated cirrhotic patients
2012 · Alfredo Hierro González, Olga Marina Hano García, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction–Associated Steatotic Liver Disease
2026 · Leyla de Avila, Khalid M. AlNaamani, et al. · JAMA
Erratum: Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study
2026 · Zobair M. Younossi, Leyla de Avila, et al. · Hepatology
Amiloidosis de mesenterio y vasos sanguíneos / Amyloidosis of the mesentery and blood vessel
2026 · Fernández Sotolongo, José, Ortiz Montero, Yosvani Josué, et al. · Archivos del Hospital Universitario "General Calixto García"
PDF
OS-097 Liver fibrosis is the only predictor of adverse outcomes: time to remove metabolic dysfunction associated steatohepatitis (MASH) resolution as a clinical trial endpoint
2026 · Zobair M. Younossi, Ming-Lung Yu, et al. · Journal of Hepatology
TOP-113 Clinical profile, histologic features, non-invasive test accuracy, and long-term outcomes of lean metabolic dysfunction associated steatotic liver disease (MASLD): insights from the global masld project
2026 · Zobair M. Younossi, Leyla de Avila, et al. · Journal of Hepatology
Performance of Non-invasive Tests (nits) and Predictors of Outcomes in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (masld) From Latin America and North America
2025 · Zobair Younossi, Leyla de Avila, et al. · Annals of Hepatology
TOP-395 A global analysis of patients with metabolic dysfunction associated steatotic liver disease with liver biopsy, non-invasive tests and mortality
2025 · Zobair Younossi, Leyla de Avila, et al. · Journal of Hepatology
LBP-024 Metabolic dysfunction- and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort
2025 · Zobair Younossi, Leyla de Avila, et al. · Journal of Hepatology
Tumores del estroma gastrointestinal: experiencia en el Instituto de Gastroenterología
2024 · González Fabian, Licet, Antezana Rodríguez, Jhurien René, et al. · Archivos Cubanos de Gastroenterología
PDF
Works count: 50
Citation count: 111
H-index: 5
I10-index: 3
Year
Topic
Type